Drug intelligence / Profile preview

IRDye 700DX

Development stage
Unknown
Lead developer
Rakuten Medical
Modality
Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

IRDye 700DX is a near-infrared (NIR) phthalocyanine dye that functions as a highly flexible photosensitizer. It is primarily used in the development of photoimmunotherapy (PIT), where it is conjugated to monoclonal antibodies or other targeting molecules to form target-specific photosensitizer conjugates. Upon binding to target cells and subsequent activation with NIR light (typically at 690 nm), the dye induces rapid disruption of cell membrane integrity, leading to necrotic cell death. This mechanism enables selective destruction of targeted cells, such as tumor cells or regulatory T cells within tumors, while minimizing off-target effects. The technology has been developed for both research applications (e.g., imaging and detection) and therapeutic purposes in oncology, particularly for cancers like head and neck squamous cell carcinoma[5][7][8].

Brand names
IRDye 700DXIRDye700DXIRDye-700DX
Other names
Irdye 700dx NHS esterIrdye700dx NHS esterIrdye-700dx NHS esterIR700IR-700IR 700UNII-C51A2YUX4NUNII-C-51A2YUX4NUNII-C 51A2YUX4N

Beyond the preview

Go deeper on IRDye 700DX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IRDye 700DX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call